PortfoliosLab logoPortfoliosLab logo
VMD vs. IMOS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

VMD vs. IMOS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Viemed Healthcare Inc (VMD) and ChipMOS TECHNOLOGIES INC. (IMOS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VMD achieves a 65.68% return, which is significantly lower than IMOS's 159.12% return.


VMD

1D
0.41%
1M
17.80%
6M
70.03%
YTD
65.68%
1Y
82.64%
3Y*
10.19%
5Y*
11.57%
10Y*

IMOS

1D
1.90%
1M
23.93%
6M
109.77%
YTD
159.12%
1Y
319.32%
3Y*
55.23%
5Y*
23.07%
10Y*
21.60%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VMD vs. IMOS - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
VMD
Viemed Healthcare Inc
65.68%-7.36%2.17%3.84%44.83%-32.73%25.16%63.16%122.18%
IMOS
ChipMOS TECHNOLOGIES INC.
159.12%64.28%-27.86%34.76%-32.61%49.82%12.33%38.76%-4.97%

Correlation

The correlation between VMD and IMOS is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Jan 4, 2018

0.12

Fundamentals

Market Cap

VMD:

$471.93M

IMOS:

$2.65B

EPS

VMD:

$0.37

IMOS:

NT$9.58

PE Ratio

VMD:

33.38

IMOS:

253.69

PS Ratio

VMD:

1.73

IMOS:

4.57

PB Ratio

VMD:

3.46

IMOS:

3.47

Total Revenue (TTM)

VMD:

$286.57M

IMOS:

NT$18.75B

Gross Profit (TTM)

VMD:

$163.52M

IMOS:

NT$2.12B

EBITDA (TTM)

VMD:

$46.09M

IMOS:

-NT$130.72M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VMD vs. IMOS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VMD
VMD Risk / Return Rank: 9090
Overall Rank
VMD Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
VMD Sortino Ratio Rank: 8686
Sortino Ratio Rank
VMD Omega Ratio Rank: 8888
Omega Ratio Rank
VMD Calmar Ratio Rank: 9494
Calmar Ratio Rank
VMD Martin Ratio Rank: 9393
Martin Ratio Rank

IMOS
IMOS Risk / Return Rank: 9898
Overall Rank
IMOS Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
IMOS Sortino Ratio Rank: 9797
Sortino Ratio Rank
IMOS Omega Ratio Rank: 9595
Omega Ratio Rank
IMOS Calmar Ratio Rank: 9999
Calmar Ratio Rank
IMOS Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VMD vs. IMOS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Viemed Healthcare Inc (VMD) and ChipMOS TECHNOLOGIES INC. (IMOS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VMDIMOSDifference
Sharpe ratioReturn per unit of total volatility

-2.36

Sortino ratioReturn per unit of downside risk

-1.83

Omega ratioGain probability vs. loss probability

1.34

1.51

-0.17

Calmar ratioReturn relative to maximum drawdown

4.84

12.35

-7.51

Martin ratioReturn relative to average drawdown

12.04

28.82

-16.78

VMD vs. IMOS - Sharpe Ratio Comparison

The current VMD Sharpe Ratio is 2.00, which is lower than the IMOS Sharpe Ratio of 4.36. The chart below compares the historical Sharpe Ratios of VMD and IMOS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

VMD vs. IMOS - Drawdown Comparison

The maximum VMD drawdown since its inception was -69.35%, smaller than the maximum IMOS drawdown of -98.76%. Use the drawdown chart below to compare losses from any high point for VMD and IMOS.


Loading charts...

Drawdown Indicators


VMDIMOSDifference

Max Drawdown

Largest peak-to-trough decline

-69.35%

-98.76%

+29.41%

Max Drawdown (1Y)

Largest decline over 1 year

-15.86%

-25.39%

+9.53%

Max Drawdown (3Y)

Largest decline over 3 years

-40.64%

-55.46%

+14.82%

Max Drawdown (5Y)

Largest decline over 5 years

-49.62%

-62.26%

+12.64%

Max Drawdown (10Y)

Largest decline over 10 years

-62.26%

Current Drawdown

Current decline from peak

0.00%

0.00%

0.00%

Average Drawdown

Average peak-to-trough decline

-29.22%

-60.31%

+31.09%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.62%

10.97%

-4.35%

Volatility

VMD vs. IMOS - Volatility Comparison

The current volatility for Viemed Healthcare Inc (VMD) is 7.18%, while ChipMOS TECHNOLOGIES INC. (IMOS) has a volatility of 32.11%. This indicates that VMD experiences smaller price fluctuations and is considered to be less risky than IMOS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VMDIMOSDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.18%

32.11%

-24.93%

Volatility (6M)

Calculated over the trailing 6-month period

29.60%

59.95%

-30.35%

Volatility (1Y)

Calculated over the trailing 1-year period

38.33%

71.94%

-33.61%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

40.95%

44.36%

-3.41%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

57.60%

40.12%

+17.48%

Dividends

VMD vs. IMOS - Dividend Comparison

VMD has not paid dividends to shareholders, while IMOS's dividend yield for the trailing twelve months is around 1.03%.


PositionTTM20252024202320222021202020192018201720162015
IMOS
ChipMOS TECHNOLOGIES INC.
1.03%2.77%5.90%5.52%13.62%4.46%3.84%2.61%0.80%3.49%7.28%0.71%
VMD
Viemed Healthcare Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

VMD vs. IMOS - Financials Comparison

This section allows you to compare key financial metrics between Viemed Healthcare Inc and ChipMOS TECHNOLOGIES INC.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
75.41M
219.23M
(VMD) Total Revenue
(IMOS) Total Revenue
Please note, different currencies. VMD values in USD, IMOS values in TWD

VMD vs. IMOS - Profitability Comparison

The chart below illustrates the profitability comparison between Viemed Healthcare Inc and ChipMOS TECHNOLOGIES INC. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

10.0%20.0%30.0%40.0%50.0%60.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
56.8%
13.8%
Portfolio components
VMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Viemed Healthcare Inc reported a gross profit of 42.83M and revenue of 75.41M. Therefore, the gross margin over that period was 56.8%.

IMOS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, ChipMOS TECHNOLOGIES INC. reported a gross profit of 30.20M and revenue of 219.23M. Therefore, the gross margin over that period was 13.8%.

VMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Viemed Healthcare Inc reported an operating income of 4.30M and revenue of 75.41M, resulting in an operating margin of 5.7%.

IMOS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, ChipMOS TECHNOLOGIES INC. reported an operating income of 15.92M and revenue of 219.23M, resulting in an operating margin of 7.3%.

VMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Viemed Healthcare Inc reported a net income of 2.58M and revenue of 75.41M, resulting in a net margin of 3.4%.

IMOS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, ChipMOS TECHNOLOGIES INC. reported a net income of 15.96M and revenue of 219.23M, resulting in a net margin of 7.3%.


Frequently Asked Questions


VMD and IMOS have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IMOS has higher volatility (32.11%) compared to VMD (7.18%). In terms of maximum drawdown, VMD dropped -69.35% vs IMOS's -98.76%.

IMOS currently has the higher Sharpe Ratio (4.36 vs 2.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VMD and IMOS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer